Menu
GeneBe

11-77142737-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000260.4(MYO7A):c.47T>C(p.Leu16Ser) variant causes a missense change. The variant allele was found at a frequency of 0.374 in 1,609,820 control chromosomes in the GnomAD database, including 120,171 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar. Synonymous variant affecting the same amino acid position (i.e. L16L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.47 ( 19309 hom., cov: 32)
Exomes 𝑓: 0.36 ( 100862 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 4.72
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2303141E-6).
BP6
Variant 11-77142737-T-C is Benign according to our data. Variant chr11-77142737-T-C is described in ClinVar as [Benign]. Clinvar id is 43258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77142737-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.754 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO7ANM_000260.4 linkuse as main transcriptc.47T>C p.Leu16Ser missense_variant 3/49 ENST00000409709.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO7AENST00000409709.9 linkuse as main transcriptc.47T>C p.Leu16Ser missense_variant 3/491 NM_000260.4 Q13402-1
MYO7AENST00000458637.6 linkuse as main transcriptc.47T>C p.Leu16Ser missense_variant 3/491 P1Q13402-2
MYO7AENST00000409619.6 linkuse as main transcriptc.14T>C p.Leu5Ser missense_variant 4/501 Q13402-8
MYO7AENST00000660626.1 linkuse as main transcriptc.137T>C p.Leu46Ser missense_variant 2/2

Frequencies

GnomAD3 genomes
AF:
0.467
AC:
71017
AN:
151936
Hom.:
19262
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.761
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.377
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.505
Gnomad SAS
AF:
0.429
Gnomad FIN
AF:
0.290
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.473
GnomAD3 exomes
AF:
0.393
AC:
95355
AN:
242580
Hom.:
20162
AF XY:
0.389
AC XY:
51164
AN XY:
131668
show subpopulations
Gnomad AFR exome
AF:
0.773
Gnomad AMR exome
AF:
0.370
Gnomad ASJ exome
AF:
0.383
Gnomad EAS exome
AF:
0.499
Gnomad SAS exome
AF:
0.417
Gnomad FIN exome
AF:
0.294
Gnomad NFE exome
AF:
0.345
Gnomad OTH exome
AF:
0.395
GnomAD4 exome
AF:
0.364
AC:
531187
AN:
1457764
Hom.:
100862
Cov.:
38
AF XY:
0.364
AC XY:
264100
AN XY:
724684
show subpopulations
Gnomad4 AFR exome
AF:
0.782
Gnomad4 AMR exome
AF:
0.374
Gnomad4 ASJ exome
AF:
0.383
Gnomad4 EAS exome
AF:
0.499
Gnomad4 SAS exome
AF:
0.420
Gnomad4 FIN exome
AF:
0.288
Gnomad4 NFE exome
AF:
0.343
Gnomad4 OTH exome
AF:
0.400
GnomAD4 genome
AF:
0.468
AC:
71116
AN:
152056
Hom.:
19309
Cov.:
32
AF XY:
0.464
AC XY:
34500
AN XY:
74312
show subpopulations
Gnomad4 AFR
AF:
0.761
Gnomad4 AMR
AF:
0.376
Gnomad4 ASJ
AF:
0.399
Gnomad4 EAS
AF:
0.504
Gnomad4 SAS
AF:
0.428
Gnomad4 FIN
AF:
0.290
Gnomad4 NFE
AF:
0.340
Gnomad4 OTH
AF:
0.472
Alfa
AF:
0.371
Hom.:
17956
Bravo
AF:
0.491
TwinsUK
AF:
0.343
AC:
1272
ALSPAC
AF:
0.322
AC:
1241
ESP6500AA
AF:
0.724
AC:
3006
ESP6500EA
AF:
0.342
AC:
2871
ExAC
AF:
0.399
AC:
48127
Asia WGS
AF:
0.460
AC:
1604
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 18, 2014- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 28, 2006- -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Likely benign, no assertion criteria providedliterature onlyDepartment of Ophthalmology and Visual Sciences Kyoto University-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Usher syndrome type 1 Benign:3
Benign, criteria provided, single submittercurationSIB Swiss Institute of BioinformaticsMay 31, 2018This variant is interpreted as a Benign - Stand Alone, for Usher syndrome 1B, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Autosomal recessive nonsyndromic hearing loss 2 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Autosomal dominant nonsyndromic hearing loss 11 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Usher syndrome type 1B Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.33
Cadd
Benign
21
Dann
Benign
0.48
DEOGEN2
Benign
0.21
T;T;.;.
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.13
T;T;T;T
MetaRNN
Benign
0.0000012
T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-2.2
N;.;N;.
MutationTaster
Benign
1.0
P;P;P;P
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
3.6
N;.;N;N
REVEL
Benign
0.23
Sift
Benign
1.0
T;.;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0
B;.;.;.
Vest4
0.082
MPC
0.12
ClinPred
0.030
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.036
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1052030; hg19: chr11-76853783; COSMIC: COSV68684017; API